December 21, 2017 / 11:06 AM / 9 months ago

BRIEF-Soligenix Identifies Biomarkers For Ricin Toxin Vaccine Testing Under FDA Animal Rule

Dec 21 (Reuters) - Soligenix Inc:

* SOLIGENIX IDENTIFIES BIOMARKERS FOR RICIN TOXIN VACCINE TESTING UNDER THE FDA ANIMAL RULE

* SOLIGENIX INC - BIOMARKERS FOR RICIN TOXIN VACCINE TESTING BEEN SUCCESSFULLY IDENTIFIED, FACILITATING POTENTIAL APPROVAL UNDER FDA "ANIMAL RULE"

* SOLIGENIX INC - FURTHER EFFICACY STUDIES IN NHPS EVALUATING POTENTIAL DOSING REGIMENS ARE ANTICIPATED IN 2018

* SOLIGENIX - RIVAX DEMONSTRATED REDUCED NUMBER OF VACCINATIONS MAY BE REQUIRED TO ESTABLISH PROTECTION, POTENTIALLY UTILIZING ONLY 2 DOSES INSTEAD OF 3 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below